ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,427,180, issued on Sept. 30, was assigned to RENOVION INC. (Chapel Hill, N.C.).
"Treatment of respiratory tract diseases and infections with ascorbic acid compositions" was invented by Dan Copeland (Chapel Hill, N.C.), Carolyn Durham (Chapel Hill, N.C.) and Thomas E. Richardson (Chapel Hill, N.C.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The application is directed to a method of inhibiting or reducing growth of clinical isolate bacteria comprising contacting the clinical isolate with a composition comprising glutathione, a glutathione derivative, a glutathione conjugate, a pharmaceutically-acceptable salt thereof, or any combination thereof."
Th...